FIELD: chemistry.
SUBSTANCE: invention relates to method of producing compound of formula I or its pharmaceutically acceptable salt, where R1 represents halogen, C1-6 alkyl or C1-6 alkoxy, and R2 represents hydrogen, which includes step for reducing compound of formula 2A to obtain compound of formula 3A and reaction of compound of formula 3A with aqueous acid to form compound of formula I. Method further involves reaction of compound of formula 4A with HONH2·HCl to obtain compound of formula 2A. Compound of formula 2A is reduced to compound of formula 3A in presence of reagent containing NaBH4, LiBH4, KBH4 or any combination thereof, and catalyst which contains CoCl2. Aqueous acid contains aqueous HCl or aqueous H2SO4. Invention also relates to compound of formula 2A.
EFFECT: technical result is thiazolidinediones synthesis method, not affecting PPARγ, which are suitable for preventing and/or treating metabolic disorders, such as diabetes, obesity, hypertension and inflammatory diseases.
13 cl, 1 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
SYNTHESIS OF THIAZOLIDINEDIONE COMPOUNDS | 2011 |
|
RU2594725C2 |
THIAZOLIDINEDIONE ANALOGUES | 2007 |
|
RU2445957C2 |
PPAR-SUPPORTING COMPOUNDS FOR TREATING METABOLIC DISEASES | 2014 |
|
RU2687490C2 |
THIAZOLIDINEDIONE SALTS WITH REDUCED AFFINITY TO PPAR FOR TREATMENT OF METABOLIC DISORDERS | 2010 |
|
RU2564661C2 |
THIAZOLIDINEDIONE ANALOGUES FOR TREATING DIABETES AND DYSLIPIDEMIA | 2008 |
|
RU2486179C2 |
METHODS AND INTERMEDIATE PRODUCTS | 2006 |
|
RU2446171C2 |
PPAR-SUPPORTING THIAZOLIDINEDIONES AND THEIR COMBINATIONS FOR TREATMENT OF NEURODEGENERATIVE DISEASES | 2010 |
|
RU2570424C2 |
METHODS AND INTERMEDIATE COMPOUNDS | 2010 |
|
RU2531588C2 |
SERINE PROTEASE INHIBITORS | 2006 |
|
RU2441020C2 |
MODULATORS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE | 2007 |
|
RU2459821C2 |
Authors
Dates
2016-08-10—Published
2011-08-09—Filed